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A B S T R A C T
Background and objectives: There is a pressing need to improve access to evidence-based practice for people with
psychosis. The primary aim of this study was to assess clinical feasibility of a manualised, evidence-based CBT
intervention (GOALS) targeting a personalised recovery goal, delivered by the frontline workforce, following
brief training. Secondly, we aimed to conduct preliminary statistical analyses of key outcomes and costs.
Methods: The GOALS study is a feasibility randomised controlled trial (ISRCTN 73188383). 75 participants with
current psychosis were recruited and randomly allocated to receive either treatment as usual alone or with
GOALS therapy.
Results: Brief training enabled frontline staff to deliver the therapy according to protocol and 74% of therapy
participants partially or fully achieved their goals. There were significant improvements with a moderate effect
size of 0.56 on goal attainment. However, preliminary statistical analyses found no significant differences be-
tween groups on our primary outcome of activity levels or other secondary outcomes Health economic analysis
found that point estimates of costs, controlling for baseline costs, implied savings (even including intervention
costs), but the difference was not statistically significant.
Limitations: The study was designed as a feasibility RCT, and therefore the results of secondary estimates of
efficacy effects should be treated with caution.
Conclusions: This approach holds promise in supporting people with psychosis to reach personal recovery goals,
cost effectively.
1. Introduction
For many with psychosis, the process of recovery and re-engaging
with life goals is impeded by persisting symptoms, low mood, anxiety
and stigma. Therefore, facilitating the achievement of valued goals is
vital, supporting service users to build a sense of meaning, connected-
ness, hope, optimism and empowerment, which form key aspects of
recovery in mental health (Le Boutillier et al., 2011; Leamy, Bird, Le
Boutillier, Williams & Slade, 2011).
There are evidence-based psychological therapies available for
psychosis which are effective (Burns, Erickson, & Brenner, 2014) in
supporting clients to reach personal goals and are recommended in
international best practice guidelines (Kreyenbuhl, Buchanan,
Dickerson, & Dixon, 2010; National Institute for Health and Care
Excellence, 2009; National Institute for Health and Care Excellence,
2014), but there is a severe implementation problem (van der Gaag,
2014). A key barrier is a lack of trained therapists able to deliver
therapies within routine services (Berry & Haddock, 2008; Pilling &
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Price, 2006; Prytys, Garety, Jolley, Onwumere & Craig, 2011). Such
therapies, including cognitive behaviour therapy (CBT) often involve
many sessions delivered by therapists following lengthy and costly
training: costs and workforce training pose severe challenges to their
implementation in the USA as in Europe and the UK (Beidas et al.,
2016; Stewart et al., 2016). It has been argued that future im-
plementation should focus on training the wider workforce to deliver
therapy as part of routine clinical practice. There is a need to evaluate
the feasibility of implementing structured, manualised brief evidence-
based CBT therapies, requiring less formal training, that can be readily
disseminated (Thase, Kingdon, & Turkington, 2014). CBT for psychosis
encompasses a wide rage of treatment targets (Morrison & Barratt,
2010), including specific symptoms, processes and personal goals
(Fowler et al., 2009; Freeman et al., 2015). Comorbid mood disorders
are highly prevalent in psychosis: although estimates vary, research
suggests that around 40% and 50% of people with psychosis also meet
criteria for an anxiety disorder or depression respectively (Achim et al.,
2011; Buckley, Miller, Lehrer, & Castle, 2009). These comorbidities are
also associated with negative impacts on psychotic symptoms (Hartley,
Barrowclough, & Haddock, 2013; Vorontsova, Garety, & Freeman,
2013). Brief, structured evidence-based therapies are available for an-
xiety and depression; namely graded exposure and behavioural acti-
vation, and there is evidence for the effectiveness of their delivery by
staff with less formal therapy experience and therefore at a lower cost
(Richards et al., 2016). This model of delivery has been used in the UK
as part of a ‘stepped care’ model allowing increased access to psycho-
logical therapies in people with anxiety and depression (Chan & Adams,
2014; Gyani, Shafran, Layard, & Clark, 2013). In those with psychosis,
these therapies are typically delivered as part of a tool box of evidence-
based therapies, where therapy is targeting anxious avoidance or de-
pression-related inactivity as barriers to personal goals; aiming to in-
crease social inclusion and engagement in meaningful activities (Fowler
et al., 2009; Morrison & Barratt, 2010). However, it is not known
whether this type of therapy could be delivered by staff with less formal
therapy training to clients with psychosis.
1.1. The GOALS study
The present study aims to examine the feasibility of training the
frontline workforce, rather than accredited psychological therapists, to
deliver targeted, brief evidence-based therapy in routine community
services for people with psychosis. In the UK, this workforce typically
provides a clinical case and crisis management function (known as ‘care
coordination’), comprising psychiatric nurses, occupational therapists,
and social workers. Many teams also include clinical assistant posts or
internships (typically psychology graduates) supervised by qualified
staff. Training the community team workforce to deliver manualised
interventions is increasingly recommended and researched (Gaughran
et al., 2013; Priebe et al., 2013).
The therapy follows a structured protocol, with a manual developed
and modified as part of an initial pilot study (Waller et al., 2012, 2015),
using evidence-based behavioural techniques of graded exposure and
behavioural activation, adapted for use in clients with psychosis (e.g.
including reference to psychotic symptoms and simplified in order to
suit all clients, including those with associated cognitive problems).
Therapy targets a personalised recovery goal over 8 sessions (plus a
one-month booster session), for which either comorbid anxiety or de-
pressive symptoms are a barrier to achievement. Training is brief: only
12 h over two days followed by ongoing case supervision. The therapy
manual and training materials were piloted: seven members of frontline
staff from a range of professional backgrounds were trained and de-
livered the therapy to 12 people with a diagnosis of psychosis and co-
morbid symptoms of anxiety and/or depression, impeding achievement
of personal goals. The results were promising, with high rates of goal
achievement and improvement in activity levels, depression, negative
symptoms of psychosis and general wellbeing (Waller et al., 2012).
The present study is a feasibility randomised controlled trial of this
intervention: GOALS (Getting On top of Anxiety and Low Mood and So
reaching your goals). The primary aims were to establish the clinical
feasibility of the intervention, in terms of participant recruitment and
satisfaction with treatment, uptake of training and delivery of therapy
and progress towards goals. A secondary aim was to provide pre-
liminary estimates of efficacy effects on key outcomes including activity
levels, goal attainment, anxiety and depression and a preliminary
health economic analysis.
2. Methods
2.1. Study design and procedures
The design is a single-blind, feasibility RCT comparing treatment as
usual (TAU) and GOALS + TAU intervention. The trial was registered
before commencing recruitment in Current Controlled Trials, ISRCTN:
73188383. Ethical approval was given by London Chelsea National
Research Ethics Committee (ref: 12/LO/1523). No significant changes
were made to the methods after trial commencement. The sample size
calculation, randomisation, blinding, data monitoring and assessment
of safety were as described in the published trial protocol (Waller et al.,
2014). Outcome assessments were completed by trained research
workers prior to randomisation (baseline), 12 weeks (post-therapy) and
18 weeks (follow-up). Following completion of baseline assessments,
randomisation was performed independently by the King's Clinical
Trials Unit, using an online system (at a 50:50 ratio at the level of the
individual; stratified according to problem focus (either anxiety or de-
pression); random permuted blocks varied in size from three to six). The
research assessors, statistician and health economist remained blind to
allocation. Only the research coordinator (HW) was unblind, in order to
enrol participants, allocate therapy and supervise trained staff. Parti-
cipants in the GOALS + TAU group were allocated to begin therapy
immediately.
2.2. Participants
Power calculations (see Waller et al., 2014) suggested 66 partici-
pants should be recruited; in practice we recruited 75 participants from
adult community secondary care services in one UK National Health
Service (NHS) Trust (South London and Maudsley NHS Foundation
Trust) between March 2013 and February 2015. Inclusion criteria were:
diagnosis of Schizophrenia Spectrum disorder or currently experiencing
psychotic symptoms; comorbid symptoms of anxiety and/or depression;
wanting to increase activity levels. Those meeting the following criteria
were excluded: receiving CBT within last three months; primary diag-
nosis of organic mental health problem or substance dependency.
2.3. Interventions
2.3.1. TAU
Participants allocated to TAU received usual treatment in primary
and secondary care. They were offered GOALS therapy after completing
the final trial assessment.
2.3.2. GOALS + TAU
Participants received eight sessions of the GOALS intervention, plus
a ‘booster’ session one month later, with a trained staff member.
Sessions were approximately one hour, weekly, following a structured
manual, with step-by-step guidance for each session, plus weekly client
handouts. Sessions took place in participants' local mental health ser-
vice teams, in their homes and/or out in the community, where ap-
propriate (e.g. when practising new skills). Key aspects included edu-
cation on symptoms of anxiety/depression, and maintenance factors of
avoidance and reduced activity levels respectively; setting a SMART
(specific, measurable, achievable, rewarding, timely) therapy goal;
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breaking the goal into smaller, manageable steps; working towards
these steps; use of coping techniques when difficulties arise. Weekly
homework tasks were set and trained staff gave participants a reminder
call between sessions to check in on progress.
2.4. Assessments
2.4.1. Feasibility
Participant recruitment and acceptability were assessed through the
number of those approached who declined treatment, plus attrition
rates. Feasibility of training and delivery were assessed by number and
proportion of those completing training, by workforce role, who de-
livered the intervention. Treatment adherence and fidelity were as-
sessed in the GOALS + TAU group through records of therapy atten-
dance, therapist attendance at supervision and examination of a sample
of audiotaped recordings of therapy sessions scored against fidelity
indicators within the therapy manual. Progress towards goals was as-
sessed by sessional ratings of goal attainment. Satisfaction and ac-
ceptability of the therapy was assessed through separate semi-struc-
tured interviews conducted by research workers and trained service
users.
2.4.2. Efficacy
The following outcomes were assessed at each time point, using
validated measures with good reported reliability. Unless otherwise
stated, higher scores indicate less favourable outcomes. Additional
checks of inter-rater reliability were made on 20% of all semi-structured
interview measures, involving ratings made by researchers: high levels
of inter-rater reliability were found.
The primary outcome was the Time Budget Measure (Jolley et al.,
2005, 2006); a semi-structured interview, used to assess weekly activity
levels (range: 0–112, where higher scores indicate higher activity le-
vels, requiring more planning, complexity and effort), validated for use
specifically in people with psychosis. The choice of primary outcome
was guided by the focus on activation/prevention of anxious avoidance
and by our pilot data (reference). Secondary outcomes were the Choice
of Outcome in CBT for Psychosis measure (a patient-rated and patient
co-designed outcome measure, CHOICE) (Greenwood et al., 2010) as-
sessed goal attainment (one item) and clinically meaningful outcomes
in CBT for psychosis (11 items; all range from 0 to 10; higher scores
indicate more favourable outcomes); the Hospital Anxiety and De-
pression Scale (HADS) (Snaith, 2003) measures of anxiety and depres-
sion (the inclusion criteria for this study included a clinical cut-off score
of 8 for either anxiety and/or depression); A modified version of the
Mobility Inventory (MI) (Chambless, Caputo, Jasin, Gracely, &
Williams,1985) assessed anxious avoidance. Participants identified five
key avoided areas from 26 situations listed in the MI, rated according to
how often they are avoided, alone or accompanied; the Positive and
Negative Syndromes Scale (PANSS) (Kay, Fiszbein, & Opler, 1987) and
the Psychotic Symptoms Rating Scales (PSYRATS) (Haddock,
McCarron, Tarrier, & Faragher, 1999) assessed psychotic symptoms; a
10-item version of the Clinical Outcomes in Routine Evaluation –
Outcome Measure (CORE-10) (Barkham et al., 2013) measured clinical
distress; the Warwick-Edinburgh Mental Well-being Scale (WEMWBS)
(Tennant et al., 2007) measured well-being (higher scores indicate
greater self-reported well-being); the Manchester Short Assessment of
Quality of Life (MANSA) (Priebe, Huxley, Knight, & Evans, 1999): a 12-
item measure of quality of life (higher scores indicate greater self-re-
ported quality of life); the Social and Occupational Functioning As-
sessment Scale (SOFAS) (American Psychiatric Association, 1994) is a
clinician-rated single score of social and occupational functioning
(higher scores indicate better functioning).
2.5. Analysis
2.5.1. Feasibility analysis
Recruitment and acceptability parameters and adherence and fide-
lity measures in the GOALS + TAU group were assessed descriptively.
Relevant parameters (proportions, medians etc.) were estimated.
2.5.2. Statistical analysis
Statistical analyses were conducted in Stata and SPSS (IBM Corp,
2011; StataCorp, 2013). Regression modelling was employed to com-
pare outcomes between trial arms at 12 and 18 weeks, including esti-
mates of effects sizes (with associated 95% CIs) and statistical sig-
nificance tests for a preliminary efficacy assessment. Outcomes at 12 or
18 weeks formed the dependent variable and the explanatory variables
included the trial arm (i.e. GOALS + TAU or TAU), the randomisation
stratifier (main problem focus, i.e. anxiety or depression) and baseline
values of the outcome to gain extra precision. Normality assumptions of
regression models were checked for all outcomes using residual diag-
nostics. Logistic regression was used to examine whether any baseline
variables were predictive of missingness at 12 weeks, and within the
intervention arm only, Fisher's exact test was used to assess the pre-
dictive power of insufficient receipt of therapy. Only PSYRATS Hallu-
cinations was found to be predictive of missingness at 12 weeks at a
liberal 10% significance level. However, there was clear evidence for a
relationship between missingness and therapy completion (therapy was
classed as ‘insufficient’ if participants had completed ≤ 4 sessions).
‘Insufficient’ GOALS therapy predicted missingness in the intervention
group (only 2 of the 28 classed as having ‘sufficient’ therapy had a
missing value at 12 weeks contrasting with 6 of the 10 classed as having
‘sufficient’ therapy; Fisher's exact test p= .002). Therefore to generate
analyses that are valid under missing at random (MAR) assumptions
with the insufficient therapy receipt being allowed to predict missing-
ness, we employed 100 multiple imputations (Sterne et al., 2009), using
the chained equations procedure.
2.5.3. Health economic analysis
Use of health, social care and criminal justice services was measured
using an adapted version of the Client Service Receipt Inventory
(Beecham & Knapp, 2001), recorded at baseline for the previous 4-
months and follow-up. Service use data were combined with unit cost
information for 2013/14 taken from a nationally recognised source
(Netten & Curtis, 2014). Costs were adjusted for inflation, but not dis-
counted. 18-week costs were compared, controlling for baseline, using a
bootstrapped regression model to account for the likely skewed dis-
tribution of the residuals.
3. Results
Participant baseline clinical and demographic characteristics are
summarised in Table 1. All distributions appear reasonably balanced
across trial arms, and reflect the diversity of the target population.
3.1. Primary aim: clinical feasibility of intervention
3.1.1. Recruitment
166 participants were referred (see Fig. 1); 118 agreed to meet for
eligibility screening. Of those screened, 89 (75.4%) met inclusion cri-
teria. Of those eligible at initial screen, 79 (88.8%) gave consent to take
part and 75 (94.9%) of these were randomised. Attrition rates were low:
65 (86.7%) and 70 (93.3%) participants completed assessments at 12
and 18 weeks respectively. Recruitment ceased once sufficient numbers
of participants were recruited, based on the power calculation.
3.1.2. Staff training
There was a good uptake of training but lower rates of utilizing
training to deliver therapy: 53 staff members completed training; 27
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went on to work with one or more supervised therapy cases. Of these,
only four (14.8%) were in case management roles, 10 (37.0%) were
other health professionals (e.g. occupational therapists, vocational
specialists) and 13 (48.1%) were graduate psychologists in clinical as-
sistant/internship posts. The workforce had little previous therapy ex-
perience (median previous days CBT training=2; range=0–20), but
most had experience working with psychosis (median years in psychosis
services= 2.5; range= 1–20).
3.1.3. Treatment adherence and fidelity
At post-treatment and follow-up, participants attended a median of
6 (range=0–8) and 8 (range= 0–9) therapy sessions respectively.
Therapy was classed as ‘insufficient’ if participants had completed ≤
4sessions: at follow-up 10 (26.3%) of the 38 participants had ‘in-
sufficient therapy’. Clinical assistants delivered the highest mean
number of sessions and percentage of cases rated as ‘sufficient therapy’
(median=9 sessions, range=0–9; 20 cases (83.3%)), followed by case
managers (median= 7 sessions, range= 0–8; 3 (75%)) and other
health professionals (median=4.5 sessions, range=0–9; 5 (50%)).
Supervision attendance was high, with sufficient attendance (fort-
nightly meetings) in 33 of the 38 therapy cases (86.8%). Audio re-
cordings were rated for fidelity to five key aspects of the therapy pro-
tocol (rated as 0 (incomplete), 1 (partially complete) or 2 (complete),
giving a total score ranging from 0 to 10 for each session) in 60 therapy
sessions. Inter-rater reliability was high: the average measures ICC for
the fidelity ratings, based on 12 recorded sessions, was 0.92, F
(11,12)= 13.21, p < .001. Fidelity was high, with a mean total
session rating of 8.73 (sd= 1.31). Closer examination of fidelity ratings
however indicated the protocol was followed around goal setting and
achievement, but the most commonly missed aspects of therapy related
to establishing links between the chosen goal and anxiety/depression.
3.1.4. Progress towards goals
Of the 38 participants randomised to GOALS + TAU, 18 (47.4%)
achieved their goal, 10 (26.3% partially achieved their goal) and 10
(26.3%) did not achieve their goal. All participants who made no pro-
gress towards their goal were in the ‘insufficient therapy’ group.
Common goals concerned health and exercise (21.1% of goals), socia-
lising (21.1%) and hobbies/interests (23.7%).
3.1.5. Participant satisfaction and feedback
Participants reported high levels of treatment satisfaction, particu-
larly valuing progress made towards goals, therapist support, and
therapy materials.
3.1.6. Adverse events
There were seven adverse events documented across the study
period: six in the TAU group (2 emergency psychiatric admissions; 1
physical health hospital admission; 3 Emergency room visits, without
admission) and one in the GOALS + TAU group, but rated unrelated to
the intervention (emergency room visit, following burglary).
3.2. Secondary aim: preliminary efficacy assessment
3.2.1. Outcomes by trial arm and assessment time point
Estimated effect sizes for various outcomes and time points are
shown in Table 2. There was no effect on our primary outcome of ac-
tivity, measured by the Time Budget Measure. There was a significant
improvement, on our secondary outcome of goal attainment, with an
estimated moderate effect size of 0.56 at follow-up, favouring the
GOALS + TAU group. All other differences between the two trial arms
at either post-intervention or follow-up were estimated to be of small
effect size (< 0.35) and tested not statistically significant at a liberal
10% level.
3.2.2. Health economic analysis
Numbers of participants using services and their mean estimated
costs are presented in Table 3, across both trial arms and at the two
measured time points (four months prior to baseline and the four
months between baseline and follow-up). At baseline, total cost in the
GOALS+ TAU group is almost twice as high as TAU, but over follow-up
it is around a third lower compared to TAU. Costs at follow-up were
£890 lower in the intervention group (controlling for baseline costs),
which was however not statistically significant (bootstrapped 95% CI
-£2313 to £150).
4. Discussion
Monotherapy with medication is no longer the optimal treatment
choice for people with psychosis. However, internationally there is a
severe implementation challenge in extending access to additional
evidence-based practices for this group.
The results suggest one such recovery-oriented evidence-based
practice, GOALS therapy, is suitable for people with psychosis in
community settings: the majority of those screened met eligibility cri-
teria (75.4%), and a high proportion of those gave consent (94.9%) and
completed the study (93.3% completed follow-up assessments), in-
dicating a fit with the target population. All participants who had
‘sufficient therapy’ were able to achieve or partially achieve their per-
sonal recovery goal, within an average of 8 sessions, which they had
been unable to achieve independently. Achievement of personally
meaningful goals is an important part of the recovery process from
severe mental illness in that it is likely to instil hope for the future, build
Table 1
Baseline clinical and demographic characteristics by trial arm and for the whole
participant sample.
Variable GOALS + TAU
Intervention
(N=38)
TAU
(N=37)
Total
Sample
(N=75)
Median age in years (range) 39 (20–69), N=38 32 (19–66),
N=37
37 (19–69),
N=75
Median age leaving education
in years (range)
17 (13–31), N=37 18 (14–25),
N=35
18 (13–31),
N=72
Median years in contact with
mental health services
(range)
12 (0–39), N=36 6 (0–54),
N=37
10 (0–54),
N=73
Gender:
Female 15 (39.5%) 17 (46.0%) 32 (42.7%)
Male 23 (60.5%) 20 (54.0%) 43 (57.3%)
Ethnicity:
White 20 (52.6%) 14 (37.8%) 34 (45.3%)
Black 12 (31.6%) 18 (48.7%) 30 (40.0%)
Asian 3 (7.9%) 2 (5.4%) 5 (6.7%)
Other 3 (7.9%) 3 (8.1%) 6 (8.0%)
Diagnosis:
Schizophrenia type
disorder
28 (73.7%) 29 (78.4%) 57 (76.0%)
Mood disorder with
psychotic symptoms
7 (18.4%) 5 (13.5%) 12 (16.0%)
First episode
psychosis
3 (7.9%) 3 (8.1%) 6 (8.0%)
Marital status:
Divorced/Separated 3 (7.9%) 2 (5.4%) 5 (6.7%)
Married/Cohabiting 6 (15.8%) 2 (5.4%) 8 (10.7%)
Single 29 (76.3%) 33 (89.2%) 62 (82.7%)
Current employment status:
Unemployed 35 (92.1%) 34 (91.9%) 69 (92.0%)
Employed 2 (5.3%) 2 (5.4%) 4 (5.3%)
Voluntary/unpaid
work
1 (2.6%) 1 (2.7%) 2 (2.7%)
CBT in previous year:
No 30 (90.9%) 25 (89.3%) 55 (90.2%)
Yes 3 (9.1%) 3 (10.7%) 6 (9.8%)
Service pathway:
Early Intervention 9 (23.7%) 15 (40.5%) 24 (32%)
Recovery 29 (76.3%) 22 (59.5%) 51 (68%)
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a sense of empowerment and confidence in one's coping abilities, and
make connections with others and the local community (Le Boutillier
et al., 2011; Leamy et al., 2011). Participants gave positive feedback
regarding treatment satisfaction: results of a full qualitative analysis of
this feedback will be reported elsewhere.
Our preliminary statistical analyses mirrored the feasibility data,
indicating a moderate effect size on attainment of a personal recovery
goal, favouring the GOALS + TAU group. Interestingly, this positive
goal attainment was not reflected in change in activity levels on the
Time Budget Measure, our predefined primary outcome measure. This
may reflect some insensitivity of the measure to meaningful but subtle
changes in activity in one specific goal-related domain, which will be
important to consider when choosing the most appropriate measures for
future trials. There was also unexpectedly little impact on anxiety and
Fig. 1. GOALS study CONSORT diagram.
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depression, despite our earlier positive pilot data and in contrast to
research examining similar approaches in those with common mental
disorders (Richards et al., 2016). However, whilst staff kept to the
protocol when setting and working towards recovery goals, they were
less likely to make links to difficulties associated with mood: this
finding has informed a number of subsequent modifications to both the
training and manual, to enhance targeting of anxiety and depression.
The health economic analysis was however promising: the cost point
estimates, after controlling for baseline differences, imply savings, even
including intervention costs, although in this feasibility study the dif-
ference is not statistically significant.
The findings have important implications for the model of therapy
delivery and its limitations, which is reported and discussed in more
detail elsewhere (Garety et al., 2018). In summary, all frontline staff
who saw a study participant were able to deliver the therapy to protocol
and support participants attending sufficient therapy sessions to reach a
personal goal. However, there were differences between workforce
roles, specifically those with and without case and crisis management
responsibilities. Despite positive evaluations of the training package
and enthusiasm to try out the GOALS therapy under supervision, a large
proportion of staff in case management roles felt unable to take on a
study participant following training citing time pressures and the need
to prioritise crisis work. Clinical assistants not carrying case or crisis
management responsibility in contrast worked with most participants,
had highest levels of fidelity to the therapy protocol, and highest rates
of participant session attendance and goal attainment, despite having
the least previous mental health training or experience in psychosis
services. We suggest that improving service quality by widening access
to evidence-based psychological therapies for psychosis requires a
realistic approach, and there is a case for developing a new frontline
entry level workforce with roles dedicated at least in part to proto-
colised brief therapy delivery, as has been successfully undertaken in
the UK for those with common mental disorders by the development of
Psychological Well-Being Practitioner roles (Chan & Adams, 2014;
Gyani, Shafran, Layard, & Clark, 2013).
4.1. Limitations
The GOALS Study was designed as a feasibility, rather than defini-
tive randomised controlled trial, and therefore the results of the
statistical analysis should be treated with caution. For the majority of
trained staff members, their study participant was their first ever
therapy case. Supervision attendance was also considered part of the
training process, so there is a possibility that with more experience and
hands on learning through supervision, staff would become more pro-
ficient in therapy delivery.
Following the findings from the feasibility data and experience of
delivering training and supervision modifications have been made to
the protocol and training package. For example, given the finding that
trained staff tended to commonly struggle to make links between per-
sonal goals and anxious avoidance/depression-related inactivity,
training has been lengthened to include further teaching on this. In
addition, both training and the therapy manual have more information
on basic therapy techniques such as the use of socratic questioning
rather than more didactic approaches. Further, additional areas of
troubleshooting difficulties were added to the therapy manual and
client handouts, based on common difficulties arising in the study.
Finally, a more flexible approach to the number of therapy sessions has
been suggested, since not all participants needed the full number of
sessions to reach their goal, whilst others needed additional sessions.
4.2. Conclusions
This feasible and low cost intervention thus has great potential to
widen access to evidence-based practice for people with psychosis, if a
modified approach, based on the findings of the current study, is shown
to be cost–effective in a larger trial in routine services.
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Table 3
Number of participants using services and mean estimated cost of services in past four months.
Service Baseline, n (%); mean 2013/14 cost (sd) 18-wk follow-up, n (%); mean 2013/14 cost (sd)
GOALS + TAU
(n=38)
TAU
(n=37)
GOALS + TAU
(n=34)
TAU
(n=36)
GOALS intervention – – 34 (100); £482 (261) –
General practitioner 27 (71); £67 (70) 24 (65); £111 (144) 24 (71); £73 (91) 27 (75); £82 (109)
Psychiatrist 30 (79); £203 (217) 27 (73); £146 (220) 25 (74); £140 (141) 18 (50); £113 (205)
Other doctor 5 (13); £16 (58) 3 (8); £16 (85) 6 (18); £36 (88) 5 (14); £31 (114)
Psychologist 7 (18); £72 (222) 7 (19); £113 (391) 7 (21); £59 (142) 8 (22); £92 (236)
Home treatment/crisis team 11 (29); £120 (391) 3 (8); £44 (186) 2 (6); £43 (173) 1 (3); £7 (43)
Social worker 7 (18); £27 (67) 11 (30); £42 (99) 3 (9); £13 (48) 8 (22); £44 (103)
Mental health nurse 32 (84); £251 (254) 33 (89); £223 (207) 29 (85); £151 (151) 27 (75); £220 (271)
Occupational therapist 4 (11); £11 (38) 6 (16); £13 (34) 7 (21); £24 (52) 10 (28); £82 (170)
Other professionalsa 13 (34); £970 (4756) 22 (59); £272 (625) 14 (41); £61 (141) 13 (36); £220 (271)
Day careb 12 (32); £646 (2878) 19 (51); £428 (986) 12 (35); £425 (1307) 20 (56); £1040 (2930)
Inpatient care 4 (11); £1402 (4909) 2 (5); £138 (596) 0 (0); £0 (0) 4 (11); £1040 (2930)
Criminal justice 1 (3); £1 (7) 0 (0); £0 (0) 3 (9); £8 (28) 2 (6); £11 (45)
Medication 37 (97); £245 (362) 36 (97); £269 (443) 34 (100); £360 (561) 34 (94); £251 (408)
Mean (SD) Total Costs £4030 (£7021) £1811 (£1524) £1766 (£1462) £2610 (£3586)
Key: sd, standard deviation.
a Includes contact with drug and alcohol advisor and other counsellor/therapist services.
b Includes contact with drug and alcohol service, day care centre, drop-in centre, self-help/support group, leisure centre and adult education classes and other day
care services.
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